SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950142-09-001969
Filing Date
2009-12-18
Accepted
2009-12-18 16:54:20
Documents
1
Group Members
DR. ALASTAIR J.J. WOODHARRI V. TARANTOMARK KESSELSYMPHONY CAPITAL GP, L.P.SYMPHONY CAPITAL PARTNERS, L.P.SYMPHONY GP, LLCSYMPHONY VIDA HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 sc13da4_oxi.htm SC 13D/A 288305
  Complete submission text file 0000950142-09-001969.txt   290207
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Subject) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45691 | Film No.: 091250637
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 950 PARK AVE APT. 11A NEW YORK NY 10028
Business Address
KESSEL MARK (Filed by) CIK: 0001222013 (see all company filings)

Type: SC 13D/A